This week there were 24 Top Picks and 3 ETF in a wide range of industries: ETF, Financials, Technology, Healtcare, Consumer, Basic Materials, Industrials, Energy, Telecommunications and Utilities.
Here are this week’s Top Picks as selected by: David Cockfield, Fabrice Taylor, James Hodgins, Brooke Thackray, Michael Sprung, Ryan Bushell, Jaime Carrasco, Robert McWhirte, Michael Simpson and David Driscoll.
If you have a growth part of your portfolio, it should be in the TFSA. You want maximum growth in TFSA so he would not recommend it for these accounts.
Get similar or better returns with less risk, beta, volatility. Well constructed product. Skews more to certain sectors like utilities and financial services, so you'll see underperformance. For 5-10-15-20 years, it's a thoughtful way to get returns from the market. Try XMV, which creates a portfolio of minimum volatility. You could use these 2 ETFs…
Small cap stocks in the US. It has been hit the hardest. It is a great place to come out of this. Buy it lower than today.
Strongest capital position of all the big 6 banks. Their interest in Schwab can be monetized. Want to expand their already large US presence. Loan growth should pick up. Will benefit when regulatory restrictions are lifted. Should continue to increase dividends. Yield is 3.61%. (Analysts’ price target is $93.28)
Canadian banks have generally moved higher but in the short term they tend to play leapfrog. In recent years other have leapt ahead. (Analysts’ price target is $86.15)
It is the most discounted insurance company in Canada. It is trading at this level because it has been the performance laggard for quite some time. It has become a show-me story. However if you were going to buy an insurance company, this would be the one to buy. There is the chance of a…
Populated by public and private investments in India. One stock he would tuck away for 10 years. India is the largest democracy, and corporate tax cuts have been encouraging. Fundamentals are looking great for India.
He has been investing in this for almost three years now. They received Health Canada approval for a new brain stimulation medical device last fall. They are awaiting FDA approval in the US. It magnifies the result of physio-therapy for the brain and the technology is safe. It is a billion dollar business if it…
(A Top Pick Apr 21/20, Down 4%) Hurt during Covid by surgeries not being performed. Should have a strong 2021.
They report Thursday. They have a high-growth healthcare business that they partly picked up from GE for a song. He expects a great quarter.
They own a series of food distribution businesses. It appears they are not making any money from them. It appears to be a scale problem.
They have done stunningly well over the last 20 years but for a large company it gets increasingly difficult to grow at decent rates, so he is thinking of selling it.
Has held it since 2015. He would keep this at a certain allocation and would add to it if it dips below your chosen percentage. If you buy a good asset, continue to add by maintaining asset allocation. He is buying it for the long term. The money that comes in with the upshot will…
(A Top Pick Mar 01/21, Up 10%) Strong season from January to May. Now is its weak period, so he wouldn't buy right now.
Allan Tong’s Discover Picks NTR stocks are currently hitting all-time highs right below $80. There’s a little more upside that the street sees with a price target of $80.67, though I predict the low-$80s is more likely. Cyclical stocks are trades, not long-term holds, so there’s wiggle room to earn a 5-8% return if you’re…
It's a work in progress royalty company in gold and precious metals. Only three years old, it's very active by deploying $70 million of capital. Only two of their 45 assets are actually producing with two more coming on this year. So, there'll be a rapid advance in cash flow. The dividend is small but…
Allan Tong’s Discover Picks Bay Street is sticking by Chorus. Analyst signals remain at four buys and two holds for CHR stock. The new $5.18 price target amounts to more than 10% upside. With flights expected to resume sometime this summer, this PT is reasonable. Chorus’ management has steered the company well through the Covid…
(A Top Pick Jan 17/19, Up 68%) This is artificial intelligence that is replacing people in call centres. These are insurance and financial call centres. He expects there to still be a long runway to come. This trades in France.
(A Top Pick Jan 17/19, Down 7%) He blames the CFO for the loss. They were signing contracts that were not compliant and their guidance was off. Even though the stock is down, if they have earnings of 3.20 per share range, the stock is fully valued. If they make 4.20 next year, the stock…
They're in northeast BC where Tourmaline is consolidating land and assets, near LXE. So, LXE will become topical. LXE has reached an inflection point after acquiring a lot of land and pushed the Montney play to the northeast. Now, they need a lot of capital to move to full development. They're talking to potential buyers,…
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues fell short of estimates by 8% but EPS was 4% better at $1.16. Outlook is good despite losing Keystone. Comfortable buying at 14x earnings. Unlock Premium - Try 5i Free
Not a name you should buy. Deleveraging due to excess debt from paying dividends longer than they should have and acquisitions. The stock is trading at 3.7x which is a premium to the group. Free cashflow is at 31% yield at $70 oil. Could see meaningful dividend but there are better names.
Big fan of telecoms, though they didn't deliver last year as expected. Telecoms are very defensive and operate in an oligopoly. RCI is OK, but not as keen on it compared to others in the space. Least enthusiastic about cable. Ton of risk on the Shaw deal.
They operate well in renewables, though the entire space has pulled back this. So, now is a good entry point. They just issued equity to buy an onshore-wind Spanish company, which diversifies NPI beyond offshore wind.
EMA-T vs. FTS-T. Both companies distribute electricity. He has more FTS-T than EMA-T. You are looking at the growth in the size of the pie as well as the configuration. Both get paid a regulated rate of return. FTS-T has a little more exposure than EMA-T. Both stocks have bounced off the bottom this year.…
Be cautious putting money into utilities right now, unless you need the income. With the call on cyclicals, you might get some better opportunities to add to those names. As rates move higher, typically those stocks sell off. In Canada, FTS is world class, 5% earnings and dividend growth, predictable 10% return.